Northern Trust
EPIX

Northern Trust’s ESSA Pharma EPIX Stock Holding History

Northern Trust’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-12,489
Closed -$33.7K – 4490
2023
Q2 		$33.7K Hold
12,489
– – ﹤0.01% 4306
2023
Q1 		$37.1K Buy
12,489
+761
+6% +$2.24K ﹤0.01% 4329
2022
Q4 		$29.6K Sell
11,728
-140
-1% -$402 ﹤0.01% 4400
2022
Q3 		$22K Buy
11,868
+199
+2% +$524 ﹤0.01% 4527
2022
Q2 		$37K Sell
11,669
-13,275
-53% -$74.2K ﹤0.01% 4487
2022
Q1 		$154K Sell
24,944
-615
-2% -$5.41K ﹤0.01% 4216
2021
Q4 		$363K Buy
25,559
+4,102
+19% +$45.7K ﹤0.01% 3929
2021
Q3 		$172K Sell
21,457
-7,500
-26% -$119K ﹤0.01% 4240
2021
Q2 		$827K Buy
28,957
+16,904
+140% +$491K ﹤0.01% 3576
2021
Q1 		$350K Buy
+12,053
New +$280K ﹤0.01% 3923

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return